Pharmacokinetic Modeling of Paracetamol Uptake and Clearance in Zebrafish Larvae : Expanding the Allometric Scale in Vertebrates with Five Orders of Magnitude
Zebrafish larvae (Danio rerio) are increasingly used to translate findings regarding drug efficacy and safety from in vitro-based assays to vertebrate species, including humans. However, the limited understanding of drug exposure in this species hampers its implementation in translational research. Using paracetamol as a paradigm compound, we present a novel method to characterize pharmacokinetic processes in zebrafish larvae, by combining sensitive bioanalytical methods and nonlinear mixed effects modeling. The developed method allowed quantification of paracetamol and its two major metabolites, paracetamol-sulfate and paracetamol-glucuronide in pooled samples of five lysed zebrafish larvae of 3 days post-fertilization. Paracetamol drug uptake was quantified to be 0.289 pmole/min and paracetamol clearance was quantified to be 1.7% of the total value of the larvae. With an average volume determined to be 0.290 μL, this yields an absolute clearance of 2.96 × 107 L/h, which scales reasonably well with clearance rates in higher vertebrates. The developed methodology will improve the success rate of drug screens in zebrafish larvae and the translation potential of findings, by allowing the establishment of accurate exposure profiles and thereby also the establishment of concentration-effect relationships.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
Zebrafish - 13(2016), 6 vom: 21. Dez., Seite 504-510 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kantae, Vasudev [VerfasserIn] |
---|
Themen: |
362O9ITL9D |
---|
Anmerkungen: |
Date Completed 25.10.2017 Date Revised 13.11.2018 published: Print-Electronic Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM264373391 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM264373391 | ||
003 | DE-627 | ||
005 | 20231224205938.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2016 xx |||||o 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0881.xml |
035 | |a (DE-627)NLM264373391 | ||
035 | |a (NLM)27632065 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kantae, Vasudev |e verfasserin |4 aut | |
245 | 1 | 0 | |a Pharmacokinetic Modeling of Paracetamol Uptake and Clearance in Zebrafish Larvae |b Expanding the Allometric Scale in Vertebrates with Five Orders of Magnitude |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.10.2017 | ||
500 | |a Date Revised 13.11.2018 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Zebrafish larvae (Danio rerio) are increasingly used to translate findings regarding drug efficacy and safety from in vitro-based assays to vertebrate species, including humans. However, the limited understanding of drug exposure in this species hampers its implementation in translational research. Using paracetamol as a paradigm compound, we present a novel method to characterize pharmacokinetic processes in zebrafish larvae, by combining sensitive bioanalytical methods and nonlinear mixed effects modeling. The developed method allowed quantification of paracetamol and its two major metabolites, paracetamol-sulfate and paracetamol-glucuronide in pooled samples of five lysed zebrafish larvae of 3 days post-fertilization. Paracetamol drug uptake was quantified to be 0.289 pmole/min and paracetamol clearance was quantified to be 1.7% of the total value of the larvae. With an average volume determined to be 0.290 μL, this yields an absolute clearance of 2.96 × 107 L/h, which scales reasonably well with clearance rates in higher vertebrates. The developed methodology will improve the success rate of drug screens in zebrafish larvae and the translation potential of findings, by allowing the establishment of accurate exposure profiles and thereby also the establishment of concentration-effect relationships | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a allometry | |
650 | 4 | |a drug discovery | |
650 | 4 | |a metabolism | |
650 | 4 | |a paracetamol | |
650 | 4 | |a pharmacokinetics | |
650 | 4 | |a zebrafish | |
650 | 7 | |a Analgesics, Non-Narcotic |2 NLM | |
650 | 7 | |a Acetaminophen |2 NLM | |
650 | 7 | |a 362O9ITL9D |2 NLM | |
700 | 1 | |a Krekels, Elke H J |e verfasserin |4 aut | |
700 | 1 | |a Ordas, Anita |e verfasserin |4 aut | |
700 | 1 | |a González, Oskar |e verfasserin |4 aut | |
700 | 1 | |a van Wijk, Rob C |e verfasserin |4 aut | |
700 | 1 | |a Harms, Amy C |e verfasserin |4 aut | |
700 | 1 | |a Racz, Peter I |e verfasserin |4 aut | |
700 | 1 | |a van der Graaf, Piet H |e verfasserin |4 aut | |
700 | 1 | |a Spaink, Herman P |e verfasserin |4 aut | |
700 | 1 | |a Hankemeier, Thomas |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Zebrafish |d 2004 |g 13(2016), 6 vom: 21. Dez., Seite 504-510 |w (DE-627)NLM175388040 |x 1557-8542 |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2016 |g number:6 |g day:21 |g month:12 |g pages:504-510 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 13 |j 2016 |e 6 |b 21 |c 12 |h 504-510 |